Pharmacokinetics and Pharmacodynamics Practice Questions

Q: All of these fluids are isotonic except

3% Normal saline. ***3% Normal saline*** - This fluid is **hypertonic**, meaning it has a higher solute concentration (osmolality ~1025 mOsm/L) than normal body fluids (~280-295 mOsm/L). - It is definitively **not isotonic** [1] and is used to correct severe hyponatremia by drawing water from the intracellular to the extracellular space. - This is the **clearest answer** as it is unambiguously non-isotonic. *5% dextrose* - This solution is **isotonic when infused** (~252 mOsm/L, close to plasma osmolality) but becomes **hypotonic physiologically** as the dextrose is rapidly metabolized, leaving free water [1]. - While technically isotonic at administration, it behaves as a hypotonic solution in the body. - Commonly used for dehydration and as a vehicle for medications. *0.9% Normal saline* - Often called **normal saline**, this is an **isotonic** crystalloid solution (~308 mOsm/L), with osmolality similar to blood plasma [1]. - Widely used for volume expansion, rehydration, and as a maintenance fluid in various clinical settings. *Ringer lactate* - This is an **isotonic** crystalloid solution (~273 mOsm/L) containing sodium, chloride, potassium, calcium, and lactate. - It closely mimics the electrolyte composition of plasma and is preferred for fluid resuscitation and in surgical settings due to its balanced composition.

Q: Elimination of alcohol follows

Zero order kinetics. ***Zero order kinetics*** - Alcohol is metabolized at a **constant rate** (approximately 7-10 grams per hour) regardless of its concentration in the body. - This occurs because the metabolic enzymes like **alcohol dehydrogenase (ADH)** become **saturated** at blood alcohol concentrations typically achieved during drinking. - A **fixed amount** of alcohol is eliminated per unit of time, not a fixed percentage. - **Clinical significance**: This explains why you cannot speed up alcohol elimination by drinking coffee or taking cold showers. *Third Order kinetics* - This kinetic order is **not typically observed** for drug elimination in biological systems. - It would imply an extremely complex relationship between concentration and elimination rate that is not seen in clinical pharmacology. *First order kinetics* - Most drugs follow **first-order kinetics**, where a **constant fraction** (percentage) of the drug is eliminated per unit of time. - This occurs when enzyme systems are **not saturated**, which is **not the case** with alcohol at typical intoxicating doses. - At very low blood alcohol concentrations (below enzyme saturation), alcohol may exhibit first-order kinetics. *Second order kinetics* - **Second-order kinetics** means the elimination rate is proportional to the **square of the drug concentration**. - This type of kinetics is **rarely relevant** for drug elimination in pharmacology.

Q: Alkalinization of urine is done in the management of poisoning with:

Aspirin. ***Aspirin*** - Alkalinization of urine is done in **aspirin overdose** to promote the **excretion of salicylic acid**, which is acidic. - By increasing the urine pH, more of the acidic aspirin metabolites become **ionized**, reducing their reabsorption in the renal tubules and increasing their elimination. *Morphine* - Morphine elimination is primarily through **hepatic metabolism** (glucuronidation) and subsequent renal excretion of inactive metabolites. - Urinary pH manipulation has **little impact** on its clearance. *Amphetamine* - Amphetamine is a **weak base**, and its excretion is enhanced by **acidification of urine**. - Alkalinization of urine would **increase reabsorption** and reduce its elimination, which is the opposite of what is desired in toxicity. *Atropine* - Atropine is primarily eliminated through **hepatic metabolism and renal excretion** of both unchanged drug and metabolites. - Manipulation of urinary pH has **minimal clinical utility** in enhancing its elimination.

Q: Corticosteroid which needs least systemic monitoring is:

Budesonide. ***Budesonide*** - This **corticosteroid** has a very high **first-pass metabolism** in the liver, leading to low systemic bioavailability. - Due to its localized action and minimal systemic exposure, it requires the **least systemic monitoring** compared to other corticosteroids. *Dexamethasone* - Has a **long half-life** and potent **glucocorticoid activity**, leading to significant systemic effects. - Requires careful monitoring for side effects like **hyperglycemia**, osteoporosis, and immune suppression. *Prednisolone* - A commonly used oral corticosteroid with **intermediate systemic potency** and half-life. - Requires monitoring for a range of systemic side effects, including **adrenal suppression** and fluid retention. *Hydrocortisone* - This is a short-acting corticosteroid, and its systemic use can lead to **significant mineralocorticoid effects** in addition to glucocorticoid effects. - Requires monitoring for electrolyte imbalances, **hypertension**, and other systemic corticosteroid side effects.

Q: Which of the following is the shortest acting benzodiazepine?

Midazolam. ***Midazolam*** - **Midazolam** has a very short half-life (1.5-2.5 hours) and undergoes rapid metabolism, making it suitable for procedures needing **brief sedation** or inducing anesthesia. - Its quick onset and offset are due to its high lipid solubility and hepatic metabolism, leading to its prevalent use in **surgical and diagnostic settings**. *Alprazolam* - **Alprazolam** has an intermediate half-life (6-20 hours) and is commonly used for **anxiety disorders** and panic attacks. - While relatively fast-acting, its duration of action is significantly longer than Midazolam. *Chlordiazepoxide* - **Chlordiazepoxide** is a long-acting benzodiazepine with a half-life ranging from 5 to 30 hours, and its active metabolites can extend its effects even further. - It is often used for **alcohol withdrawal syndrome** and generalized anxiety. *Diazepam* - **Diazepam** is a long-acting benzodiazepine with a half-life of 20-100 hours, and its active metabolites (like desmethyldiazepam) have even longer half-lives. - It is used for conditions like **anxiety, muscle spasms, and seizures**, requiring prolonged therapeutic effects.

Q: Laudanosine is a toxic metabolite of?

Atracurium. ***Atracurium*** - Atracurium undergoes **Hofmann elimination**, a non-enzymatic degradation process, which produces **laudanosine** as a metabolite. - **Laudanosine** can accumulate, particularly in patients with renal or hepatic dysfunction, and at high concentrations, it may cause **CNS excitation** and seizures. *Mivacurium* - Mivacurium is rapidly metabolized by **plasma pseudocholinesterase**, an enzyme also responsible for the breakdown of succinylcholine. - Its breakdown products do not include laudanosine, and it has a relatively **short duration of action** due to this rapid metabolism. *Vecuronium* - Vecuronium is primarily eliminated by the **liver** and, to a lesser extent, the kidneys, with metabolites having some neuromuscular blocking activity. - It does not undergo Hofmann elimination and therefore does not produce laudanosine as a metabolite. *Pancuronium* - Pancuronium is primarily eliminated by the **kidneys**, with a significant portion excreted unchanged. - It is a long-acting neuromuscular blocker and does not produce laudanosine as a metabolite.

Q: In noncompetitive antagonism, the true statement is:

Vmax decreased; Km value normal. ***Vmax decreased; Km value normal*** - In **noncompetitive antagonism**, the antagonist binds to an **allosteric site** on the enzyme, altering its conformation and reducing its efficacy regardless of substrate concentration. - This results in a **reduced maximum velocity (Vmax)** because the antagonist effectively removes some enzyme molecules from participating in catalysis, but the **affinity (Km)** of the remaining active sites for the substrate is unaffected. *Km value increased; Vmax increased* - An **increased Km value** indicates a **decreased affinity** of the enzyme for its substrate, while an **increased Vmax** implies **enhanced catalytic activity**, which is not characteristic of any type of antagonism. - This pattern would suggest an enzyme that has been modified to bind less effectively but process substrate more rapidly, which is biologically uncommon in antagonism. *No change in Vmax; Km value decrease* - A **decreased Km value** signifies an **increased affinity** of the enzyme for its substrate, meaning it takes less substrate to reach half of the maximum velocity. - No change in Vmax combined with a decreased Km value is characteristic of **reversible competitive inhibition** at high substrate concentrations, not noncompetitive antagonism. *Km value decrease; Vmax decreases* - A **decreased Km value** suggests an **increased affinity**, meaning the enzyme binds more tightly to the substrate. - This combination is not typical for an antagonist; a reduced Vmax without a change in Km is characteristic of noncompetitive antagonism, while a decreased Km would imply improved binding.

Q: Among atracurium and cisatracurium, which of the following does not require dose modification in patients with renal or hepatic failure?

Both atracurium and cisatracurium. ***Both atracurium and cisatracurium*** - Both **atracurium** and **cisatracurium** are metabolized primarily via **Hofmann elimination**, a non-enzymatic chemical degradation. - This mechanism is independent of renal or hepatic function, making them safe choices for patients with organ failure without requiring dose adjustment. *Cisatracurium* - While **cisatracurium** is known for its metabolism via **Hofmann elimination**, excluding atracurium from this category is incorrect. - Atracurium also undergoes significant Hofmann elimination, sharing this characteristic for organ-independent metabolism. *Atracurium* - While **atracurium** is metabolized via **Hofmann elimination**, excluding cisatracurium is incorrect, as cisatracurium also primarily utilizes this pathway. - Both agents are advantageous in patients with renal or hepatic impairment. *Neither atracurium nor cisatracurium* - This statement is incorrect because both drugs demonstrate metabolism independent of renal or hepatic function, which is a key advantage. - Their primary degradation pathway, **Hofmann elimination**, ensures that their elimination is not significantly affected by organ dysfunction.

Q: A patient presents with nephrotic syndrome and hypoalbuminemia. Protein binding of which drug is not affected?

Morphine. ***Morphine*** - Morphine is a **low protein-bound drug** (<35%), meaning a significant portion circulates freely. - Therefore, even with **reduced albumin levels** in nephrotic syndrome, the free fraction available for action is not significantly altered. *Valproate* - Valproate is **highly protein-bound** (90-95%), primarily to albumin. - In conditions like nephrotic syndrome with **hypoalbuminemia**, a decreased binding capacity leads to a higher free drug fraction and increased pharmacological effect. *Diazepam* - Diazepam is also **highly protein-bound** (98%), mainly to albumin. - Like other highly bound drugs, **hypoalbuminemia** in nephrotic syndrome would increase its free fraction, potentially leading to increased side effects. *Tolbutamide* - Tolbutamide is another drug with **high protein binding** (>90%), predominantly to albumin. - Reduced albumin levels in nephrotic syndrome would result in a **higher free concentration** of tolbutamide, increasing its hypoglycemic effect and risk of adverse reactions.

Question 1

All of these fluids are isotonic except

Accepted Answer

3% Normal saline

Answer

5% dextrose

Answer

0.9% Normal saline

Answer

Ringer lactate

Question 2

True statement about drug administration is

Accepted Answer

sterile technique is needed in case of I.V. and I.M. administration.

Answer

In the inhalational route, absorption of drugs takes place from vast surfaces of alveoli - so bioavailability is high and action is very rapid.

Answer

Irritation and local tissue necrosis can be seen in case of unsuitable routes like intramuscular or subcutaneous route.

Answer

100% bioavailability is seen in case of IV route.

Question 3

Elimination of alcohol follows

Accepted Answer

Zero order kinetics

Answer

Third Order kinetics

Answer

First order kinetics

Answer

Second order kinetics

Question 4

Alkalinization of urine is done in the management of poisoning with:

Accepted Answer

Aspirin

Answer

Morphine

Answer

Amphetamine

Answer

Atropine

Question 5

Corticosteroid which needs least systemic monitoring is:

Accepted Answer

Budesonide

Answer

Dexamethasone

Answer

Prednisolone

Answer

Hydrocortisone

Question 6

Which of the following is the shortest acting benzodiazepine?

Accepted Answer

Midazolam

Answer

Alprazolam

Answer

Chlordiazepoxide

Answer

Diazepam

Question 7

Laudanosine is a toxic metabolite of?

Accepted Answer

Atracurium

Answer

Mivacurium

Answer

Vecuronium

Answer

Pancuronium

Question 8

In noncompetitive antagonism, the true statement is:

Accepted Answer

Vmax decreased; Km value normal

Answer

Km value increased; Vmax increased

Answer

No change in Vmax; Km value decrease

Answer

Km value decrease; Vmax decreases

Question 9

Among atracurium and cisatracurium, which of the following does not require dose modification in patients with renal or hepatic failure?

Accepted Answer

Both atracurium and cisatracurium

Answer

Cisatracurium

Answer

Atracurium

Answer

Neither atracurium nor cisatracurium

Question 10

A patient presents with nephrotic syndrome and hypoalbuminemia. Protein binding of which drug is not affected?

Accepted Answer

Morphine

Answer

Valproate

Answer

Diazepam

Answer

Tolbutamide

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?